Skip to main content
Clinical Trials/IRCT2012061110002N1
IRCT2012061110002N1Completed未知

Effect of vitamin D supplementation on insulin resistance and glycemic control in patients with diabetes type 2

Research and Technology Teputy, Diabetes Research Center0 sites120 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
21 years to 60 years (—)
Sex
All

Inclusion Criteria

  • inclusion critera :
  • 1) patients with diabetes type 2 according to ADA criteria 2011 and under treatment with oral hypoglycemic agents, 2) HbA1C = 8.5%, 3) patients with 21-60 of age, 4) BMI>20
  • exclusion criteria :
  • 1) end stage diseases of organs such as ESRD,chronic liver disease 2)GFR=30ml/min, 3) hypercalcemia and kidney stones,4)
  • known primary hyperparathyroidism,5) heart diseases included ischemic heart disease, heart failure,cardiomyopathy,6) sarcoidosis,7) TB ,8) cancer,9) history of IBD ,10) pregnancy,11) SBP/SDP=175/104 mmHg ,12) consumption of vitamin D supplement over 400 IU within 2 months prior to intervention

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Research and Technology Teputy, Diabetes Research Center

Similar Trials